Quoin Pharmaceuticals, Ltd. (QNRX) Stock Price & Growth Analysis - Tweevest

New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out

Quoin Pharmaceuticals, Ltd.

QNRX

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

4M

Biotechnology

Next Earning date - 08 May 2025

4M

Biotechnology

Next Earning date - 08 May 2025

6.00USD

0.33 ( 5.82%)

After-hours 6.12$

0.12 (2.00%)

Market Closed (as of Apr 22, 20:00 EDT)

Relative Strenght

99

Volume Buzz

-85%

Earning Acce

No

Dist 52w H.

89%

Quote Panel

Updated April 22, 2025

1W 0.00 % 1M -42.08 % 3M 1358.43 % 1Y 809.09 %

Key Metrics

Market Cap
3.53M
Shares Outstanding
588167
Share in Float
19.13M
Dividende
0

Earning Date
08 May 2025
Price Target
6
Average Volume
264871
Beta
1.609

Range
5.01-54.95
Industry
Biotechnology
Website
https://quoinpharma.com
Sector
Healthcare

Fundamentals

Relative Strength

QNRX

Sector

loading...

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

$16M

NaN%

2025-Revenue

$44.45

-263%

2025-EPS

0

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Buy

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-142.71
vs -21.27

Q2.23

N/A

-74.48
vs -1359.99

Q3.23

N/A

-68.18
vs -394.56

Q4.23

N/A

-72.73
vs -172.10

Q1.24

N/A

-38.81
vs -142.71

Q2.24

N/A

-13.64
vs -74.48

Q3.24

N/A

-16.43
vs -68.18

Q4.24

N/A

-12.24
vs -72.73

Q1.25

N/A

-7.17
vs -38.81

Q2.25

N/A

-7.70
vs -13.64

Sales Growth

YoY

Current

Estimates

Q3.22

NA

NA vs NA

Q4.22

NA

NA vs NA

Q1.23

NA

NA vs NA

Q2.23

NA

NA vs NA

Q3.23

NA

NA vs NA

Q4.23

NA

154.8K vs NA

Q1.24

NA

NA vs NA

Q2.24

NA

NA vs NA

Q3.24

NA

NA vs NA

Q4.24

-100%

NA vs 154.8K

Return on Equity

QoQ

Q1.23

-22%

-0.22
vs -0.27

Q2.23

-23%

-0.23
vs -0.22

Q3.23

-26%

-0.26
vs -0.23

Q4.23

-37%

-0.37
vs -0.26

Q1.24

-26%

-0.26
vs -0.37

Q2.24

-26%

-0.26
vs -0.26

Q3.24

-43%

-0.43
vs -0.26

Q4.24

0%

-0.00
vs -0.43

Institutionnal Ownership

QoQ

Q4.21

4

4
vs NA

NA

Q1.22

5

5
vs 4

25%

Q2.22

8

8
vs 5

60%

Q4.22

1

1
vs NA

NA

Q1.23

1

1
vs 1

NA

Earnings Growth

Latest News

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Announces Additional Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Files U.S. Patent Application for Novel Topical Formulations to Treat Netherton Syndrome and Other Skin Diseases

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications

QNRX

globenewswire.com

7 hours ago

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study